GF Fund Management’s Maravai LifeSciences MRVI Stock Holding History

GF Fund Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.3K	Sell	3,099 -142	-4%	-$613	﹤0.01%	489
2026 Q1	$9.17K	Buy	3,241 +392	+14%	+$1.33K	﹤0.01%	566
2025 Q4	$9.26K	Sell	2,849 -264	-8%	-$889	﹤0.01%	581
2025 Q3	$8.93K	Sell	3,113 -518	-14%	-$1.32K	﹤0.01%	562
2025 Q2	$8.75K	Hold	3,631	–	–	﹤0.01%	583
2025 Q1	$8.03K	Buy	3,631 +653	+22%	+$2.58K	﹤0.01%	586
2024 Q4	$16.2K	Buy	+2,978	New	+$19.2K	﹤0.01%	490

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

GF Fund Management's MRVI Position: Q2 2026 in Review

GF Fund Management reduced its Maravai LifeSciences (MRVI) stake by 4.4% in Q2 2026, selling an estimated $613 and leaving 3,099 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #489.

GF Fund Management first reported a position in MRVI in Q4 2024 and has held it in 7 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

GF Fund Management held 3,099 shares of Maravai LifeSciences worth $19.3K as of Q2 2026.
GF Fund Management sold 142 Maravai LifeSciences shares in Q2 2026, an estimated $613.
Maravai LifeSciences made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #489 holding.
GF Fund Management first reported a position in Maravai LifeSciences in Q4 2024 and has held it in 7 quarters since.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.